Trospium

359380005

Articles

Medicine Compliance Aid Stability

Regurin · Speciality European Pharma

Speciality European Pharma
Regurin
Tablets f/c 20mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light
18th September 2015

Regurin XL · Speciality European Pharma

Speciality European Pharma
Regurin XL
Capsules m/r 60mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
No special precautions for storage
Protect from light
18th September 2015

Flotros · Galen Ltd

Galen Ltd
Flotros
Tablets f/c 20mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light
18th September 2015

Lactation Safety Information

Oxybutynin
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties although long half-life increases risk of accumulation in breastfed infants
Monitor infant for anticholinergic effects, e.g. urinary retention, colic and constipation